semaglutide and mcas A newly published case series reports that GLP-1 receptor agonists (like tirzepatide) may significantly improve symptoms in patients with mast cell activation syndrome (MCAS), even in those without diabetes or Spotlight on the Mechanism of
Description
Explores GLP-1 gastric motility adaptation and whether long-term therapy changes gastric emptying, tolerance, and GI side effects in diabetes treatment.

Although hCG is the typical pregnancy hormone, there are some conditions in which this hormone can be detected without pregnancy (or without pregnancy
Discover why strength training is essential while losing weight on GLP-1 medications and how to preserve muscle for long-term results.
Semaglutide can cause dehydration and reduced saliva flow (xerostomia)

As with any supplement, individuals who are pregnant, nursing, taking medications, or with medical conditions should consult a healthcare professional before use
In fact, the STEP 4 clinical trial saw people who combined Wegovy with lifestyle changes lose an average of 10.6% of their body weight after 20 weeks, and 17% after 68 weeks